Please Wait
Applying Filters...
menu
    • menu
    Evonik

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.

    Virtual Booth

    Contact Supplier

    Temad- We think of world-class quality.

    Virtual Booth

    Contact Supplier

    Menu

    Brolucizumab

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 2Gowling WLG (Canada) LLP

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Gowling WLG (Canada) LLP

    BROLUCIZUMAB
    arrow
    The MedTech Conference
    Not Confirmed

    Gowling WLG (Canada) LLP

    Country
    arrow
    The MedTech Conference
    Not Confirmed

    Patent Expiration Date : 2029-06-25

    Date Granted : 2018-11-20

    BROLUCIZUMAB

    Brand Name : BEOVU

    Patent Number : 2727839

    Filing Date : 2009-06-25

    Strength per Unit : 6mg / 0.05mL

    Dosage Form : SOLUTION

    Human Or VET : Human

    Route of Administration : INTRAVITREAL

    Patent Expiration Date : 2029-06-25

    Date Granted : 2018-11-20

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Gowling WLG (Canada) LLP

    BROLUCIZUMAB
    arrow
    The MedTech Conference
    Not Confirmed

    Gowling WLG (Canada) LLP

    Country
    arrow
    The MedTech Conference
    Not Confirmed

    Patent Expiration Date : 2029-06-25

    Date Granted : 2018-11-20

    BROLUCIZUMAB

    Brand Name : BEOVU

    Patent Number : 2727839

    Filing Date : 2009-06-25

    Strength per Unit : 6mg / 0.05mL

    Dosage Form : SOLUTION

    Human Or VET : Human

    Route of Administration : INTRAVITREAL

    Patent Expiration Date : 2029-06-25

    Date Granted : 2018-11-20

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF